#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemolytic uraemic syndrome Mitochondrial encephalomyopathy Acute lymphocytic leukaemia Lymphatic malformation T-cell lymphoma Wolfram syndrome Mitochondrial myopathy Osteosarcoma metastatic Bronchiectasis Chronic lymphocytic leukaemia refractory Cardiac amyloidosis Adult T-cell lymphoma/leukaemia refractory Infection in an immunocompromised host Nephrotic syndrome Nasopharyngeal cancer More trials…

    Learn about Rare Diseases

    Medulloblastoma recurrent – Treatment Alveolar rhabdomyosarcoma – Diagnostics Medulloblastoma – Life with Disease Kearns-Sayre syndrome – Life with Disease Hairy cell leukaemia recurrent Sarcoidosis – Trials in Disease Mantle cell lymphoma refractory – Treatment Glycogen storage disease type II – Diagnostics Angiosarcoma recurrent Prader-Willi syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Diclofenac Diethylamine Desflurane Arginine Hydrochloride Bisacodyl Nido-361 Haemophilus Influenzae Donanemab CHLOROQUINE PHOSPHATE Eight Treg Resamirigene Bilparvovec Desloratadine Magrolimab Bgb-A445 AZD5148 Ly3454738 Lolium Perenne Pollen Extract UDONITRECTAG Gliquidone Anthoxanthum Odoratum Ads-015 More therapies…

    Learn about Your Condition

    Pelizaeus-Merzbacher disease Myxoid liposarcoma Radiation skin injury Metastases to peritoneum Infection Vesicoureteric reflux Osteomyelitis BK virus infection Conjunctivitis allergic Sarcoma Stem cell transplant Arterial disorder Ocular lymphoma Pancoast's tumour Retroperitoneal fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Obinutuzumab vs. Rituximab for Children with Steroid-Dependent and Frequent Relapsing Nephrotic Syndrome

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Nephrotic syndrome
    Investigated Drugs:
    • Obinutuzumab
    • Rituximab
    France

  • Study Comparing Rituximab and KYV-101 for Patients with Active, ACPA-Positive, Treatment-Resistant Rheumatoid Arthritis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Kyv-101
    • Rituximab
    Germany

  • Study on the Safety and Effectiveness of Cabozantinib and Lanreotide for Patients with Gastroenteropancreatic and Thoracic Neuroendocrine Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastroenteropancreatic neuroendocrine tumour disease
    Investigated Drugs:
    • Cabozantinib
    • Lanreotide
    Italy

  • Study on Controlling Coronary Risk Factors and Platelet Aggregation Using Ramipril, Acetylsalicylic Acid, and Atorvastatin Calcium Trihydrate in Patients with Heart Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Atorvastatin Calcium Trihydrate
    • Ramipril
    • Atorvastatin
    Spain

  • Study on Indocyanine Green for Patients Undergoing Emergency Surgery for Acute Cholecystitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholecystitis acute
    Investigated Drugs:
    • Indocyanine Green
    Spain

  • Study of NVL-655 for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with ALK Mutation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    • Non-small cell lung cancer
    Investigated Drugs:
    • Nvl-655
    Belgium France Germany Italy The Netherlands Spain
Previous Page
1 … 400 401 402 403 404 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!